Biotechnology and Business

Biotechnology and Business

.. ..
From BIOTECanada : Economic Importance of Biotechnology Industry to Canada

a
1. Drug Delivery Series: The Market for Oral Drug Delivery Systems: Volume 1: Kalorama Information; Aug. 1, 2001, Iss. 463089; pg.1	1. Healthcare Update - European Biotech to Be Strengthened by GRA; ABG SUNDAL COLLIER A/S; Dec. 10, 2002
2. Emerging Technologies and Opportunites in Structural Tissue Engineering; Kalorama Information; Aug.8, 2001, Iss. 326292; pg.1	2. Proteomics - The Next Biotech Wave; CANACCORD CAPITAL; Jan.10, 2002
3. MarketLooks: The U.S. Market for Home Infusion Products; Kalorama Information; May 24, 2002, Iss. 782102; pg.1	3. U.S. and Canada Chemicals: Special Report; FITCH, IBCA; Jun.6, 2001
4. MarketLooks: The Global Market for Miscellaneous Prescription Dermatological Drugs; Kalorama Information; May 9, 2002, Iss. 768945; pg.1	4. The Catalyst - The Major U.S. Chemicals Monthly; LEHMAN BROTHERS INC; Dec.9, 2002
5. MarketLooks: The Global Market for Prescription Anti-Aging and Photodamage Drugs; Kalorama Information; May 9, 2002; Iss 768819; pg.1	5. Electronic Chemicals - Forecast Revisions - MORGAN STANLEY; Dec. 5, 2002
6. MarketLooks: The Infection Control Market; Kalorama Information; Apr. 1, 2002; Iss 762197; pg.1	6. Pharmaceuticals & Healthcare Weekly - Anthrax Scare - Medicine; SGCOWEN SECURITIES CORPORATION; Oct. 19, 2001
7. MarketLooks: The Pain Management Market; Kalorama Information; Apr. 1, 2002, Iss. 762108; pg.1	7. Monthly Drug Tracker - Compilation of Pharmaceutical Trends ...; SALOMON SMITH BARNEY; Dec. 10, 2002
8. MarketLooks: The Biological Response Modifier Market; Kalorama Information; Apr. 1, 762109; pg.1	8. Medical Technology: This Week in Med Tech Part 1; MERRILL LYNCH MORNING MEETING NOTES; Dec. 9, 2002
9. MarketLooks: The Antinauseants and Antiemetics Market; Kalorama Information; Apr. 1, 2002, Iss. 762106; pg.1	9. Drugs - U.S. Drug Weekly Valuation; SALOMON SMITH BARNEY; Dec. 9, 2002
10. MarketLooks: The U.S. Market for Sports Medicine Products; Packaged Facts; Sep. 10, 2001, Iss. 711712; pg.1	10. Health Care Worldwide - Industry Report; LEHMAN BROTHERS, iNC.; Jan.8, 1996
11. MarketLooks: The U.S. Market for OTC H2 Receptor Antagonists; Kalorama Information; Jun. 1, 2001; Iss. 678192; pg.1	11. AJA Tech Bits & Bytes - Technology Research Highlights; MERRILL LYNCH CAPITAL MARKETS; Dec.6, 2002
12. The U.S. Market for OTC Gastrointestinal Products; Kalorama Information; Jun. 1, 2002, Iss. 326302; pg. 1	12. Electronic & Electrical Equipment - A Play on Late 2002 Consumer.....; BNP/PARIBAS; Dec. 2 2002

The BioWorld Biotechnology State of the Industry Report for 2004 is now found in the stacks along with the other annuals since 2002 (at oversize HD9999.B44). It "tracks every phase of the industry's progress during 2003 and examines trends likely to continue through 2004/2005....Compiled and updated by the editors of BioWorld Today, the daily biotechnology newspaper, this executive-level analysis puts the current biotechnology year in focus and provides insight into the industry's future. It offers 441 pages on new product development, biotech stock performance, corporate deals, scientific breakthroughs, and more! This report is an essential planning tool that biotech executives turn to throughout the year."
Students and faculty in this stream will also probably want to look at The Bioworld 2003 Genomics Review: The Race for Drugs. (BUS oversize HD9999.G45B56) According to the publisher "this sophisticated 368-page report offers a detailed profile of the genomics industry from its formative years to its explosive present. Learn about the companies pioneering gene-based drug development and find out about the latest technology in gene discovery and functional genomics. The Race for Drugs provides comprehensive profiles on more than 200 public and private companies, including the major international players and small, newly public companies. Also included is an expanded section on the key emerging technologies of pharmacogenomics and proteomics, as well as details on nearly 1,000 genomics collaborations

A grain of truth : the media, the public, and biotechnology Susanna Hornig Priest.

Body bazaar : the market for human tissue in the biotechnology age Lori Andrews and Dorothy Nelkin.

21st century manufacturing Paul Kenneth Wright.

Technology, growth, and development : an induced innovation perspective Vernon W. Ruttan.

Managing frontiers in competitive intelligence edited by Craig S. Fleisher, David L. Blenkhorn.

Genetically modified organisms in agriculture : economics and politics edited by Gerald C. Nelson.

Leading biotechnology alliances : right from the start Alice M.Sapienza and Diana Stork.

From the ground up : rethinking industrial agriculture Helena Norberg-Hodge, Peter Goering, John Page.

The coming biotech age : the business of bio-materials Richard W. Oliver. Link to e-book

Directory of venture capital Kate Lister, Tom Harnish.

Report on the bioindustry of Japan Canada. Dept. of Foreign Affairs & International Trade.

Biotechnology and cleaner production in Canada Kim Ah-You, Moe Suleiman, John Jaworski.

A consumer's guide to GM food : from green genes to red herrings Alan McHughen.

Biotechnology : information on prices of genetically modified seeds in the United States and Argentina : report to the Chairman, Subcommittee on Risk Management, Research, and Specialty Crops, Committee on Agriculture, House of Representatives / United States General Accounting Office.

The international politics of biotechnology : investigating global futuresedited by Alan Russell and John Vogler.

Canadian biotechnology '98 : success from excellence : BIOTECanada's first report on the Canadian biotechnology industry
Joyce Groote, Paul Hough, Rick Walter ; in collaboration with Industry Canada ... [et al.]

International strategy and market performance in new biotechnology firms Joseph E. Coombs.

The coming biotech age : the business of bio- materials Richard W. Oliver. Link to e-book

Annual report Canadian Biotechnology Advisory Committee.

The emergence and growth of biotechnology : experiences in industrialised and developing countries Rohini Acharya.

Industry Analysis

The map and chart below were taken from the following book which is available in the Business Library or electronically: Profile and prospects of the biopharmaceutical industry in Atlantic Canada

from: Red Herring November 1999
(Although you may get many "hits" when you search the web, the
chart above indicates that at this time the "best" search engines
cover less than 25% of the Web's estimated 800 million pages.)

Feature In Western News

“Winds of Change Sweep Through the Forest City: London Bets on Biotechs” read the headline in the National Post (Aug.13, 2001,c7) As well, the article from Western News provided above and recent activities at Western and Ivey indicate a growing interest in the biotechnology sector. For these reasons the staff in the Business Library created this brief electronic guide to some of the resources that exist in the Western Libraries. Sample articles are provided along with a brief list of books. In addition, there is a biotech analysis from S&P and a chart and a map which indicate the level of activity of this sector in Canada. For more information related to biotechnology or to have a page like this created for your course be sure to visit the Western Libraries either electronically or in person.